Mirador Capital Partners »

Athira Pharma shares owned by Mirador Capital Partners

Quarter-by-quarter ownership of Athira Pharma (ATHA) shares owned by Mirador Capital Partners from 13F filings

Historical chart of Mirador Capital Partners investment in Athira Pharma

Tip: Access up to 7 years of quarterly data

All positions including Athira Pharma held by Mirador Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Athira Pharma by Mirador Capital Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $57k 21k 2.74

More positions owned by Mirador Capital Partners

Invesco Exch Trd Slf Idx Bulshs 2024 Hy (BSJO)
Invesco Exch Trd Slf Idx Bulshs 2025 Hy (BSJP)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Chevron Corporation (CVX)
Microsoft Corporation (MSFT)
Blackstone Group Inc Com Cl A (BX)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Kkr & Co (KKR)
Abbvie (ABBV)
Alphabet Cap Stk Cl A (GOOGL)
Phillips 66 (PSX)

View all positions for Mirador Capital Partners

Top funds holding Athira Pharma

Perceptive Advisors
Baker Bros. Advisors
Vanguard Group
Simplify Asset Management
Propel Bio Management
Tang Capital Management
BML Capital Management
Millennium Management
Pathstone Holdings
Citadel Advisors
Dimensional Fund Advisors
Two Sigma Investments
GSA Capital Partners
Two Sigma Advisers
Jacobs Levy Equity Management

View all funds holding Athira Pharma